CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,878 | -64.5% | 25,011 | -45.6% | 0.00% | – |
| Q2 2023 | $481,693 | -77.5% | 45,987 | -71.1% | 0.00% | -100.0% |
| Q2 2022 | $2,142,000 | -27.2% | 159,247 | +5.3% | 0.00% | – |
| Q1 2022 | $2,943,000 | -35.0% | 151,169 | +15.0% | 0.00% | -100.0% |
| Q4 2021 | $4,527,000 | -67.3% | 131,424 | -48.0% | 0.00% | -60.0% |
| Q3 2021 | $13,837,000 | -72.0% | 252,569 | -62.4% | 0.01% | -73.7% |
| Q2 2021 | $49,420,000 | +270.9% | 672,301 | +361.4% | 0.02% | +216.7% |
| Q1 2021 | $13,326,000 | -23.8% | 145,695 | -32.4% | 0.01% | -33.3% |
| Q4 2020 | $17,482,000 | +678.7% | 215,644 | +347.2% | 0.01% | +800.0% |
| Q3 2020 | $2,245,000 | – | 48,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |